ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thomas J. Takach
George J. Reul, Jr
Denton A. Cooley
J. Michael Duncan
James J. Livesay
Grady L. Hallman
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takach, T. J.
Right arrow Articles by Frazier, O. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takach, T. J.
Right arrow Articles by Frazier, O. H.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1997;64:16-22
© 1997 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Is an Integrated Approach Warranted for Concomitant Carotid and Coronary Artery Disease?

Thomas J. Takach, MD, George J. Reul, Jr, MD, Denton A. Cooley, MD, J. Michael Duncan, MD, David A. Ott, MD, James J. Livesay, MD, Grady L. Hallman, MD, O. H. Frazier, MD

Department of Cardiovascular Surgery, Texas Heart Institute, Houston, Texas


    Abstract
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Surgical Procedures
 Data Analysis
 Results
 In-Hospital Events
 Predictors of Results and...
 Comment
 References
 
Background. The management of patients with severe, concomitant coronary and carotid artery occlusive disease is controversial.

Methods. Between 1975 and 1996, 512 patients (mean age, 64.9 years; 70% male) were admitted for coronary revascularization; 316 (61.7%) had asymptomatic, severe carotid disease (stenosis >70%) and 196 (38.3%) had symptomatic carotid disease (159 [31.1%] with transient ischemia and 37 [7.2%] with completed stroke). In group 1, coronary revascularization and carotid endarterectomy were simultaneously performed in 255 patients (49.8%) with unstable angina. In group 2 (staged approach), carotid endarterectomy was performed before coronary revascularization in 257 patients (50.2%) without unstable angina.

Results. Before 1986, the incidence of stroke and death was greater in group 1 (n = 149) than in group 2 (n = 156) (14 [9.4%] versus 4 [2.6%]; p < 0.01). Since 1986, outcomes in group 1 (n = 106) and group 2 (n = 101) have been similar for stroke (2 [1.9%] versus 2 [2.0%]), death (4 [3.8%] versus 3 [3.0%]), and myocardial infarction (4 [3.8%] versus 5 [5.0%]). Significant univariate and multivariate predictors of adverse outcome were primarily heart-related (reoperation, intraaortic balloon use, ejection fraction <0.50, and angina grade 4 for death; age >70 years and congestive heart failure for stroke).

Conclusions. Despite highly selected populations, contemporary surgical results do not indicate that staged treatment of severe, concomitant coronary and carotid artery occlusive disease has an advantage over simultaneous treatment. Advances in myocardial protection and perioperative hemodynamic management may account for the low incidences of stroke and death in these operations.


    Introduction
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Surgical Procedures
 Data Analysis
 Results
 In-Hospital Events
 Predictors of Results and...
 Comment
 References
 
See also page 22.

Patients who have concomitant coronary and carotid artery occlusive disease represent a high-risk population whose management remains controversial. As the population ages and more high-risk patients are referred for treatment, surgeons are increasingly faced with the complex decisions that accompany treatment of these patients. The incidence of significant carotid stenosis in patients undergoing cardiac operations in the early 1980s was 3.8% in a study of 4,047 patients [1]. Recent studies, however, have reported that the incidence of hemodynamically significant carotid lesions is between 11% and 20% [24]. On the basis of logistic regression analysis, significant carotid stenosis has been identified as the most powerful predictor of perioperative stroke in patients with concomitant disease [4].

An integrated treatment approach involving the timing of carotid endarterectomy (CEA) for patients who have both carotid and coronary artery disease is favored by many surgeons [5]. In this approach, patients with concomitant disease are treated in either a staged (CEA first, followed by coronary revascularization [CABG] at a second operation) or simultaneous (CEA and CABG during the same period of anesthesia) fashion based on the severity of the cardiac findings. This approach evolved in an attempt to minimize the adverse outcomes of stroke and death, which were found to be increased in early, influential studies examining the simultaneous treatment of concomitant disease [6, 7].

This article examines our experience with simultaneous and staged operative treatment of concomitant coronary and carotid artery occlusive disease over a 21-year period. We undertook the study to identify factors associated with adverse outcomes, to examine trends in outcome over time, and to establish the benefits and drawbacks of each approach.


    Material and Methods
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Surgical Procedures
 Data Analysis
 Results
 In-Hospital Events
 Predictors of Results and...
 Comment
 References
 
Patients
We reviewed the individual hospital records and postoperative clinical charts of 512 consecutive patients with concomitant, severe coronary and carotid artery occlusive disease who were treated at this institution between June 1975 and June 1996. From each chart, data were obtained for 51 separate variables. Where necessary, supplemental information was obtained from the patient's private cardiologist and family. Demographic and clinical characteristics of the patients in this report are summarized in Tables 1 and 2GoGo.


View this table:
[in this window]
[in a new window]
 
Table 1. . Patient Demographics, Risk Factors, and Operative Characteristics
 

View this table:
[in this window]
[in a new window]
 
Table 2. . Patients' Presenting Status
 
All patients were admitted to the hospital because they had symptoms of cardiac disease; their carotid artery occlusive disease was diagnosed incidentally. All patients had evidence of coronary insufficiency and either symptomatic cerebral insufficiency, severe (greater than 70%) carotid artery stenosis, or a completed stroke. Patients who had a history of neurologic symptoms or stroke, discernable carotid bruit by auscultation, concomitant peripheral vascular occlusive disease, or advanced age were screened for potential carotid occlusive disease by noninvasive duplex ultrasonography.

All patients underwent full invasive radiologic evaluation including cineangiography of coronary vessels and arch aortography with runoff views of carotid and vertebral circulations. Vessel stenosis was determined angiographically by the formula [1 - (diameter at the point of greatest stenosis/diameter at the point of greatest patency)] x 100%. Bilateral carotid stenosis was defined as a narrowing greater than 50% in each vessel. Preocclusive stenosis was defined as a narrowing greater than 90% in a carotid vessel. Severe stenosis was defined as carotid artery narrowing of at least 70% of the vessel diameter.

Patients with carotid artery occlusive disease were classified by status as symptomatic or asymptomatic. Symptomatic patients included those who had focal, transient neurologic symptoms, amaurosis fugax, or a completed stroke. Asymptomatic patients had no evidence of neurologic findings. However, each of these patients had at least 70% stenosis at the carotid bifurcation.

Patients with coronary insufficiency were classified as having stable or unstable coronary insufficiency. Unstable coronary insufficiency was defined as prolonged (more than 15 minutes) angina, usually with reversible ischemic electrocardiographic changes and partial or no response to maximal medical therapy. Stable coronary insufficiency was defined as angina, usually long-standing, easily controlled with medications.

Operative interventions were classified as elective, urgent, and emergent. Urgent operations were undertaken in patients whose accelerated symptoms required immediate hospital admission for evaluation and who were judged to be too unstable to discharge before operative intervention. Emergent operations were undertaken in patients with accelerated symptoms so unstable that immediate operative intervention was required.

Patients with symptomatic or severe carotid disease and unstable angina were treated with simultaneous CEA and CABG. Those patients who had similar carotid artery disease but stable angina, however, were treated with initial CEA followed by CABG at a later date during the same hospitalization. Patients with asymptomatic carotid disease, carotid stenosis of less than 70%, and coronary insufficiency were treated with CABG alone.

Perioperative myocardial infarction was defined as either new Q waves or the elevation of the myocardial fraction of creatine kinase in association with persistent ST segment changes or new conduction abnormalities. Perioperative stroke was defined as new neurologic, focal change on physical examination with or without radiologic confirmation (via computed tomography) of infarction.


    Surgical Procedures
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Surgical Procedures
 Data Analysis
 Results
 In-Hospital Events
 Predictors of Results and...
 Comment
 References
 
Coronary revascularization and CEA procedures were done in all patients in either staged or simultaneous fashion. All procedures were performed by the same surgeons and operative team. Patients in the simultaneous procedure group underwent CEA with the chest open but before institution of cardiopulmonary bypass for CABG.

All CEAs were performed under general anesthesia with high-dose barbiturate administration during clamp occlusion. The depth of anesthesia and barbiturate administration were controlled by intraoperative encephalography. Head placement was strictly monitored to prevent compromise of the collateral blood supply. Intraoperative blood pressure and cardiac rhythm were continuously monitored and maintained especially during periods of arterial clamping. Intraoperative carotid shunts were used selectively based on evaluation of collateral blood flow.

Myocardial protection was achieved with one of several methods. Hyperkalemic crystalloid cardioplegia delivered in an antegrade fashion was initially used early in the operative series. Over the course of this series, methods of myocardial protection evolved to include cold blood cardioplegia, retrograde administration of cardioplegic solution via the coronary sinus, and warm blood cardioplegia induction and reperfusion.


    Data Analysis
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Surgical Procedures
 Data Analysis
 Results
 In-Hospital Events
 Predictors of Results and...
 Comment
 References
 
Independent and summarized operative outcomes were analyzed between groups and time periods by {chi}2 analysis and the two-tailed Fisher's exact test. Significant univariate independent predictors of adverse outcome were determined by Fisher's exact test analysis. Significant multivariate determinants of adverse outcome were obtained by logistic regression analysis. Statistical analysis was performed using SAS software (Statistical Analysis Systems Institute, Cary NC).


    Results
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Surgical Procedures
 Data Analysis
 Results
 In-Hospital Events
 Predictors of Results and...
 Comment
 References
 
Demographic and preoperative clinical findings for all patients are summarized in Tables 1 and 2GoGo. In general, the patients in this series were older and had more cardiac and noncardiac risk factors than the patients treated at this institution who need only CEA or CABG. Because we attempted to avoid performing simultaneous procedures except in patients with a higher risk of stroke or death, the patients receiving simultaneous operative treatment had a significantly greater percentage of advanced atherosclerotic and cardiac disease.


    In-Hospital Events
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Surgical Procedures
 Data Analysis
 Results
 In-Hospital Events
 Predictors of Results and...
 Comment
 References
 
Before 1986, the incidence of stroke and death was significantly greater in the simultaneous group than in the staged group (p < 0.01). Since 1986, however, outcomes in the staged and simultaneous groups have been similar for stroke (2 [1.9%] versus 2 [2.0%]), death (4 [3.8%] versus 3 [3.0%]), and myocardial infarction (4 [3.8%] versus 5 [5.0%]) (Table 3Go).


View this table:
[in this window]
[in a new window]
 
Table 3. . Adverse Outcomes After Staged and Simultaneous Operative Approaches
 
In the staged group, crescendo angina or electrocardiographic changes consistent with acute ischemia developed in 9 patients (3.5%) after initial CEA. They were taken emergently to operation, where they underwent coronary revascularization. Of these 9 patients, 3 had acute myocardial infarctions postoperatively and 1 died. Also in the staged group, 5 patients (1.9%) had strokes, 1 after carotid endarterectomy and 4 after coronary revascularization. Two (40%) of these strokes were contralateral. Ten patients in the simultaneous group had strokes, 3 (30%) of which were contralateral.


    Predictors of Results and Causal Associations
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Surgical Procedures
 Data Analysis
 Results
 In-Hospital Events
 Predictors of Results and...
 Comment
 References
 
Significant predictors of hospital death, postoperative myocardial infarction, and postoperative stroke are listed in Table 4Go. The independent predictors of adverse outcome were primarily heart related. For death, they were reoperation, intraaortic balloon use, Canadian Cardiovascular Society angina class 4, and ejection fraction less than 0.50. For myocardial infarction, they were reoperation, previous myocardial infarction, intraaortic balloon use, and extended bypass time (>80 minutes). For stroke, they were age greater than 70 years and congestive heart failure. Generalized and advanced atherosclerosis, including peripheral vascular disease and renal insufficiency, were also independent predictors of death. Neither an intraoperative carotid shunt nor patch closure of the carotid vessels was an independent predictor of stroke. The operative approach (simultaneous or staged) was not a predictor for either stroke or death.


View this table:
[in this window]
[in a new window]
 
Table 4. . Independent Predictors of Adverse Outcome
 
Events and factors that were associated with stroke or death and that may have contributed to these adverse outcomes are summarized in Table 5Go. Death occurred after either pump failure, myocardial infarction, or arrhythmia in 10 (71%) of 14 patients and after complications of stroke in only 3 (21%) of 14 patients. Hemodynamic instability or arrhythmia, however, were present in 10 (67%) of the 15 strokes that occurred during both the simultaneous and staged approaches.


View this table:
[in this window]
[in a new window]
 
Table 5. . Causal Associations and Adverse Outcomes
 

    Comment
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Surgical Procedures
 Data Analysis
 Results
 In-Hospital Events
 Predictors of Results and...
 Comment
 References
 
Preventing a stroke after coronary revascularization is a complex and multifaceted problem. The degree of carotid bifurcation disease may be the major factor contributing to the occurrence of postoperative stroke. Other factors, however, may be equally important. Carotid bifurcation disease may be a marker of generalized atherosclerosis, including the aortic arch, arch vessels, and intracranial vessels. Generalized atherosclerosis may increase the likelihood of hemorrhage, watershed ischemia, or emboli, all of which may result in stroke. In patients with such disease, perioperative hemodynamic stability and effective operative management can minimize the negative impact of generalized atherosclerosis and may therefore be increasingly important in preventing stroke. Our findings lend support to this hypothesis: we noted that variables including hemodynamic instability, arrhythmia, advanced age, and the presence of congestive heart failure were associated with the occurrence of stroke.

Therapeutic and technical advances in the areas of myocardial protection, patient monitoring, and medical management directly influence operative management and may contribute to the low incidence of stroke and death in our contemporary surgical results. As it may be inappropriate to compare the dollar cost of patient hospitalizations in 1975 with those in 1996, it may likewise be inappropriate to compare operative outcomes from those years.

Treatment options for the management of patients with concomitant disease include performing only CEA or CABG, sequentially staging CEA and CABG, or synchronously performing CEA and CABG. Both staged (Fig 1Go) and simultaneous (Fig 2Go) operative approaches provide superior results when compared with historical data reporting the results of isolated CEA or isolated CABG performed in patients with concomitant disease. Isolated CEA undertaken in patients with known, uncorrected coronary artery disease has been associated with operative mortality rates as high as 20% [8, 9], primarily the result of myocardial infarction. Isolated CABG performed in patients with known, significant carotid artery stenosis produced a mean stroke rate of 4.1% in 344 asymptomatic patients and 8.2% in 97 symptomatic patients in a total of 14 series reviewed by Rizzo and associates in 1992 [10].



View larger version (29K):
[in this window]
[in a new window]
 
Fig 1. . Results after staged and simultaneous operative approaches from the same institution. (THI = Texas Heart Institute results [this study].)

 


View larger version (32K):
[in this window]
[in a new window]
 
Fig 2. . Results after simultaneous operative approach from institutions reporting outcomes in more than 100 patients. (THI = Texas Heart Institute results [this study].)

 
Determining an advantage for either the staged or simultaneous operative approach has been controversial. In general, institutions using both staged and simultaneous operations report increased rates of stroke in the simultaneous groups [6, 8, 1114] (see Fig 1Go). However, these data are characterized by few total reports, small numbers of patients in the individual reports, excessively high morbidity and mortality rates in two reports, and, in general, a selection bias that tends to assign higher risk patients to the simultaneous approach group. We have attempted to avoid this problem by including patient populations greater than 45 patients in the staged group in both this and an earlier report [13] (see Fig 1Go).

The known benefits of the simultaneous approach include decreased exposure to anesthesia, shorter hospital stay, and significant cost savings [15]. However, early influential studies by Hertzer and colleagues [6] and Dunn [7] reported elevated stroke and mortality rates following this approach. In contrast, nine other large series [10, 13, 1621] including this study have not reported the elevated stroke and mortality rates found in those early studies (see Fig 2Go). The contemporary results of this study suggest that the simultaneous approach is as safe as the staged approach.

An ad hoc committee of the American Heart Association performed a metaanalysis on 56 English-language reports (19 of which had 50 or more patients) that dealt with simultaneous, staged, or "reversed-staged" (CEA after CABG) methods for surgical treatment of concomitant coronary and carotid artery disease [22]. The results of that study were similar to the findings in our report. In the metaanalysis, the perioperative stroke rate was similar if CEA and CABG were combined or if CEA preceded CABG. In addition, the frequencies of myocardial infarction (p = 0.01) and death (p = 0.02) were greater when CEA preceded CABG.

Our salutary results in this study must be interpreted in the context of our overall institutional results. The mortality, myocardial infarction, and stroke rates for the combined or staged approaches at our institution are higher than those rates for isolated CABG or CEA undertaken for the treatment of isolated coronary or isolated carotid disease (Table 6Go) [23]. These results reflect the higher risk and poorer medical condition of the patients with concomitant coronary and carotid disease.


View this table:
[in this window]
[in a new window]
 
Table 6. . Texas Heart Institute Outcomes: Staged, Simultaneous, and Isolated Procedures
 
Of increasing importance to cardiac surgeons is the issue of unrecognized carotid disease in patients presenting for elective coronary revascularization. These patients are at increased risk for perioperative stroke during CABG. Unrecognized carotid disease is often present in elderly patients who are asymptomatic. Ricotta and associates [4] have demonstrated that significant (>75%) carotid artery stenosis was present in 11.3% of asymptomatic patients more than 60 years old who were screened with duplex ultrasonography before elective CABG. Tuman and colleagues [24] reported that patients younger than 65 years who underwent elective coronary revascularization had a stroke rate of 0.9%, whereas asymptomatic patients older than 75 years had a stroke rate of 8.9%. Gardner and associates [25] reported a stroke incidence of 0.2% for patients younger than 45 years and of 8.0% for asymptomatic patients older than 75 years. The increasing age of patients who are undergoing CABG profoundly increases the importance of the above findings. Before coronary revascularization, we currently screen for carotid disease in asymptomatic patients with a discernible carotid bruit or who are older than 60 years, in symptomatic patients, and in patients with a history of significant peripheral vascular occlusive disease.

In summary, we conclude that an integrated approach using both staged and simultaneous operations for the treatment of concomitant coronary and carotid artery occlusive disease is unwarranted. Despite highly selected populations, contemporary surgical results in this study do not indicate that staged treatment of severe, concomitant coronary and carotid artery occlusive disease has an advantage over simultaneous treatment. A staged approach may increase hospital stay, cost of hospitalization, and the risk of development of acute ischemia and myocardial infarction after CEA and before CABG. Advances in myocardial protection and perioperative hemodynamic management may account for the low incidence of stroke and death in patients who underwent simultaneous operative treatment in this report. These findings are based on retrospective analysis, and the optimal strategy for management of patients with concomitant coronary and carotid disease will ultimately need to be established by a well-designed prospective, randomized trial.


    Footnotes
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Surgical Procedures
 Data Analysis
 Results
 In-Hospital Events
 Predictors of Results and...
 Comment
 References
 
Presented at the Forty-third Annual Meeting of the Southern Thoracic Surgical Association, Cancun, Mexico, Nov 7–9, 1996.

Address reprint requests to Dr Cooley, Department of Cardiovascular Surgery, Texas Heart Institute, PO Box 20345, Houston, TX 77225-0345.


    References
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Surgical Procedures
 Data Analysis
 Results
 In-Hospital Events
 Predictors of Results and...
 Comment
 References
 

  1. Brener BJ, Brief DK, Alpert JA, et al. The risk of stroke in patients with asymptomatic stenosis undergoing cardiac surgery: a follow-up study. J Vasc Surg 1987;5:269–79.[Medline]
  2. Faggioli GL, Curl GR, Ricotta JJ. The role of carotid screening before coronary artery bypass. J Vasc Surg 1990;12:722–9.
  3. Jausseran JM, Bergeron P, Reggi M, et al. Single staged carotid and coronary artery surgery. Indications and results. J Cardiovasc Surg 1989;30:407–13.[Medline]
  4. Ricotta JJ, Faggioli GL, Castilone A, Hasset JM. Risk factors for stroke after cardiac surgery: Buffalo Cardiac-Cerebral Group. J Vasc Surg 1995;21:359–63.[Medline]
  5. Jones EL, Hodakowski GT. Combined coronary and carotid artery disease. In: Baue AE, Geha AS, Hammond GL, Laks H, Naunheim KS, eds. Glenn's thoracic and cardiovascular surgery. Stamford CT: Appleton and Lange, 1996:2095–101.
  6. Hertzer NR, Loop FD, Beven EG, et al. Surgical staging for simultaneous coronary and carotid artery disease: a study including prospective randomization. J Vasc Surg 1989;9:455–63.[Medline]
  7. Dunn EJ. Concomitant cerebral and myocardial revascularization. Surg Clin North Am 1986;66:385–95.[Medline]
  8. Bernhard VM, Johnson WD, Peterson JJ. Carotid artery stenosis: association with surgery for coronary artery disease. Arch Surg 1972;105:837–40.[Medline]
  9. Ennix CL, Lawrie GM, Morris GC, et al. Improved results of carotid endarterectomy in patients with symptomatic coronary disease: an analysis of 1,546 consecutive carotid operations. Stroke 1979;10:122–5.[Abstract/Free Full Text]
  10. Rizzo RJ, Whittemore AD, Couper GS, et al. Combined carotid and coronary revascularization: the preferred approach to the severe vasculopath. Ann Thorac Surg 1992;52:1099–109.
  11. Mehigan JT, Buch WS, Pipkin RD, et al. A planned approach to coexistent cerebrovascular disease in coronary bypass candidates. Arch Surg 1977;112:1403–9.[Abstract]
  12. Rosenthal D, Caudill DR, Lamis PA, et al. Carotid and coronary artery disease: a rational approach. Am Surg 1984;50:233–5.[Medline]
  13. Reul GJ, Cooley DA, Duncan JM, et al. The effect of coronary artery bypass on the outcome of peripheral vascular operations in 1093 patients. J Vasc Surg 1986;3:788–98.[Medline]
  14. Carrel T, Stillhard G, Turina M. Combined carotid and coronary artery surgery: early and late results. Cardiology 1992;80:118–25.[Medline]
  15. Daily PO, Freeman AK, Dembitsky WP, et al. Cost reduction by combined carotid endarterectomy and coronary bypass grafting. J Thorac Cardiovasc Surg 1996;111:1185–93.[Abstract/Free Full Text]
  16. Jones EL, Craver JM, Michalik RA, et al. Combined carotid and coronary operations: when are they necessary? J Thorac Cardiovasc Surg 1984;87:7–16.[Abstract]
  17. Minami K, Gawaz M, Ohlmeier H, et al. Management of concomitant occlusive disease for coronary and carotid arteries using cardiopulmonary bypass for both procedures. J Cardiovasc Surg 1989;30:723–9.[Medline]
  18. Vermuelen FEE, Hamerlijnck RPHM, Defauw JJAM, Ernst SMPG. Synchronous operation for ischemic cardiac and cerebrovascular disease: early results and long-term follow-up. Ann Thorac Surg 1992;53:381–90.[Abstract]
  19. Chang BB, Darling RD III, Shah DM, et al. Carotid endarterectomy can be safely performed in patients requiring coronary artery bypass grafts. Am J Surg 1994;168:94–7.[Medline]
  20. Halpin DP, Riggins S, Carmichael JD, et al. Management of coexistent carotid and coronary artery disease. South Med J 1994;87:187–9.[Medline]
  21. Akins CW, Moncure AC, Daggett WM, et al. Safety and efficacy of concomitant carotid and coronary operations. Ann Thorac Surg 1995;60:311–8.[Abstract/Free Full Text]
  22. Moore WS, Barnett HJ, Beebe HG, et al. Guidelines for carotid endarterectomy. A multi-disciplinary consensus statement from the ad hoc committee, American Heart Association. Stroke 1995;26:188–201.[Abstract/Free Full Text]
  23. Takach TJ, Ott DA, Reul GJ, et al. Carotid endarterectomy: results in asymptomatic and symptomatic patients. Tex Heart Inst J 1996;23:42–4.[Medline]
  24. Tuman KJ, McCarthy RJ, Najafi H, Ivankovich AD. Differential effects of advanced age on neurologic and cardiac risks of coronary artery operations. J Thorac Cardiovasc Surg 1992;104:1510–7.[Abstract]
  25. Gardner TJ, Horneffer PJ, Manolio TA, et al. Major stroke after coronary artery bypass surgery: changing magnitude of the problem. J Vasc Surg 1986;3:684–7.[Medline]

Related Article

Discussion
Ann. Thorac. Surg. 1997 64: 22. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Card Surg AdultHome page
C. W. Akins and R. P. Cambria
Myocardial Revascularization with Carotid Artery Disease
Card. Surg. Adult, January 1, 2008; 3(2008): 655 - 668.
[Full Text]


Home page
ICVTSHome page
L. Nwakanma, H. K. Poonyagariyagorn, R. Bello, A. Khoynezhad, D. Smego, and K. A. Plestis
Early and late results of combined carotid endarterectomy and coronary artery bypass versus isolated coronary artery bypass
Interactive CardioVascular and Thoracic Surgery, April 1, 2006; 5(2): 159 - 165.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. W. Akins, A. D. Hilgenberg, G. J. Vlahakes, J. C. Madsen, T. E. MacGillivray, G. M. LaMuraglia, and R. P. Cambria
Late Results of Combined Carotid and Coronary Surgery Using Actual Versus Actuarial Methodology
Ann. Thorac. Surg., December 1, 2005; 80(6): 2091 - 2097.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. R. Naylor
A Critical Review of the Role of Carotid Disease and the Outcomes of Staged and Synchronous Carotid Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2004; 8(1): 37 - 42.
[Abstract] [PDF]


Home page
Card Surg AdultHome page
C. W. Akins and A. C. Moncure
Myocardial Revascularization with Carotid Artery Disease
Card. Surg. Adult, January 1, 2003; 2(2003): 627 - 637.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
Z. S. Meharwal, A. Mishra, and N. Trehan
Safety and efficacy of one stage off-pump coronary artery operation and carotid endarterectomy
Ann. Thorac. Surg., March 1, 2002; 73(3): 793 - 797.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Zacharias, T. A. Schwann, C. J. Riordan, P. M. Clark, B. Martinez, S. J. Durham, M. Engoren, and R. H. Habib
Operative and 5-year outcomes of combined carotid and coronary revascularization: review of a large contemporary experience
Ann. Thorac. Surg., February 1, 2002; 73(2): 491 - 497.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. E. Antunes, G. Anacleto, J.M. Ferrao de Oliveira, L. Eugenio, and M. J. Antunes
Staged carotid and coronary surgery for concomitant carotid and coronary artery disease
Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 181 - 186.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. L. KASISKE, M. A. VAZQUEZ, W. E. HARMON, R. S. BROWN, G. M. DANOVITCH, R. S. GASTON, D. ROTH, J. D. SCANDLING JR., and G. G. SINGER
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
J. Am. Soc. Nephrol., October 1, 2000; 11(2007): S1 - S86.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
G. L. Hines, A. R. Hartman, and S. L. Schubach
Simultaneous Redo Carotid Endarterectomy and Coronary Artery Bypass
Vascular and Endovascular Surgery, July 1, 2000; 34(4): 331 - 335.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. V. Bilfinger, H. Reda, F. Giron, F. C. Seifert, and J. J. Ricotta
Coronary and carotid operations under prospective standardized conditions: incidence and outcome
Ann. Thorac. Surg., June 1, 2000; 69(6): 1792 - 1798.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Minami, K. Fukahara, D. Boethig, A. Bairaktaris, D. Fritzsche, and R. Koerfer
LONG-TERM RESULTS OF SIMULTANEOUS CAROTID ENDARTERECTOMY AND MYOCARDIAL REVASCULARIZATION WITH CARDIOPULMONARY BYPASS USED FOR BOTH PROCEDURES
J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 764 - 772.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. Khaitan, F. P. Sutter, S. M. Goldman, T. Chamogeorgakis, M. A. C. Wertan, B. P. Priest, and J. D. Whitlark
Simultaneous carotid endarterectomy and coronary revascularization
Ann. Thorac. Surg., February 1, 2000; 69(2): 421 - 424.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Busch, H. Sirbu, I. Aleksic, S. Kazmaier, M. Friedrich, W. Buhre, and H. Dalichau
Combined approach for internal carotid artery stenosis and cardiovascular disease in septuagenarians - a comparative study
Eur. J. Cardiothorac. Surg., December 1, 1999; 16(6): 602 - 606.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. A. Borger, S. E. Fremes, R. D. Weisel, G. Cohen, V. Rao, T. F. Lindsay, and C. D. Naylor
Coronary bypass and carotid endarterectomy: does a combined approach increase risk? A metaanalysis
Ann. Thorac. Surg., July 1, 1999; 68(1): 14 - 20.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. E. Allie, M. Lirtzman, A. P. Malik, J. M. Kowalski, E. A. Barker, and C. M. Walker
Rapid-staged strategy for concomitant critical carotid and left main coronary disease with left ventricular dysfunction: IABP use
Ann. Thorac. Surg., October 1, 1998; 66(4): 1230 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. G. Johnson
Carotid endarterectomy and coronary artery bypass: The staged approach
Ann. Thorac. Surg., October 1, 1998; 66(4): 1480 - 1482.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thomas J. Takach
George J. Reul, Jr
Denton A. Cooley
J. Michael Duncan
James J. Livesay
Grady L. Hallman
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takach, T. J.
Right arrow Articles by Frazier, O. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takach, T. J.
Right arrow Articles by Frazier, O. H.
Related Collections
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS